Skip to content

Effect of Novel Thrombolytic Aptamer BB-031 on Microfluidic Thrombolysis and VWF Function Dose-Response

About
Leadership
Board of Directors
Scientific and Clinical Advisory Board
Investment Partners

Science
Approach / Novel RNA Aptamer
Mechanism of Action

Pipeline
Thrombosis
Acute Stroke
Our Solution
Clinical Trials
Publications

News
Featured News
Press Releases

Careers
Baskings Australia
Contact
Privacy Policy
Terms of Use
Sitemap

Copyright © 2024 Basking Biosciences. All Rights Reserved.

Website by Axxiem

Home
About
Science
- Approach / Novel RNA Aptamer
- Mechanism of Action
Pipeline
News
- Featured News
- Press Releases
Careers
Baskings Australia
Contact
Privacy Policy
Terms of Use
Sitemap